Research and discovery are vital for continued improvements to cancer care services. In addition to large international studies, differences in culture and environment require local data to ensure that evidence-based clinical decisions are tailored to the population of interest.

Our research program seeks to impact patient care through two streams of work:

  1. To build global research capacity through training research professionals and providing mentorship.
  2. To conduct and define research priorities on global cancer issues with the aim of driving global cancer research and innovation to advance cancer priorities internationally.

The Global Cancer Program places strong emphasis on research that is multidisciplinary and that strengthens existing collaborations between Princess Margaret Cancer Centre and partnering institutions.

Global Institute of Psychosocial, Palliative, and End-of-Life Care (GIPPEC)

Led by Dr. Gary Rodin and in partnership with other international academic centres, GIPPEC aims to generate research that informs public policy, health systems, and clinical practice in the area of psychosocial, palliative, and end-of-life care and to provide education to enhance practice and research globally.

Past Work

Global Task Force on Radiotherapy for Cancer Control (GTFRCC)
PM-DKFZ Clinician and Medical Scientist Fellows

Dr. Kira Kornienko

headshot of Rebeccca Wong

Dr. Kira Kornienko is a medical doctor specializing in Urooncology. She will be hosted in the Division of Cancer Epigenomics at the DKFZ and collaborate with PM's Functional Epigenomics Research Group on a joint project called PRO-SPeCT (PROstate cancer heterogeneity deconvolution through Single cell Profiling of Chromatin accessibility and Transcriptomic output). Generating novel insights in the progression of aggressive Prostate Cancer is a goal of this highly translational project, which could pave the way for the development of novel approaches to prevent, diagnose, stage and treat Prostate Cancer. Project results could potentially be translated back to the clinics.

Dr. Robert Vanner

headshot of Rebeccca Wong

Dr. Robert Vanner, Medical Oncology Resident, is a recipient of the DKFZ-PM Clinician and Medical Scientist Fellowship. Robert will work on a joint project entitled "Clonal Hematopoiesis as a Determinant of Metastasis and Immunotherapy Response in Breast Cancer" under the co-supervision of Dr. John Dick at the Princess Margaret Cancer Centre and Dr. Andreas Trumpp at the DKFZ. The project will investigate how clonal hematopoiesis, a process whereby a mutant hematopoietic stem cel disproportionately contributes to blood production, impacts breast cancer response to treatment and progression to metastasis. The proposed work offers the opportunity to assess if clonal hematopoiesis alters the tumour microenvironment in ways that could favour metastasis, or influences response to therapy. The intent is to better understand mechanisms promoting breast cancer metastasis and identify means to prevent this disease's deadly progression.

Clinician and Medical Scientist Fellowship Program
Last reviewed: 4/13/2021
Last modified: 4/14/2021 1:34 PM